HSD17B3 Gene - 17β-Hydroxysteroid Dehydrogenase Type 3

Key enzyme in androgen biosynthesis and male sexual development

Gene Information Card

Symbol HSD17B3
Full Name Hydroxysteroid 17-Beta Dehydrogenase 3
Gene Type Protein coding
Chromosomal Location 9q22.32
NCBI Gene ID 3293 ncbi.nlm.nih.gov/gene/3293
Ensembl ID ENSG00000130948
UniProt ID P37058
OMIM ID 264300
HGNC ID 5212
Aliases 17β-HSD3, EDH17B3, SDR12C2

Description

The HSD17B3 gene encodes 17β-hydroxysteroid dehydrogenase type 3, an enzyme primarily expressed in the testes that catalyzes the reduction of androstenedione to testosterone. This reaction is essential for androgen biosynthesis and normal male sexual differentiation. Mutations in HSD17B3 cause 46,XY disorder of sex development (46,XY DSD) due to testosterone deficiency.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
46,XY Disorder of Sex Development (46,XY DSD) due to 17β-HSD3 deficiency Loss-of-function mutations impair conversion of androstenedione to testosterone, leading to undervirilization in males ClinVar, OMIM #264300
Male Pseudohermaphroditism Deficient testosterone synthesis results in ambiguous genitalia at birth OMIM #264300
Prostate Cancer Polymorphisms in HSD17B3 may alter androgen levels and influence prostate cancer risk NCBI Gene, literature review

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 27.6 High
Adrenal Gland 0.4 Low
Prostate 0.2 Low
Ovary 0.1 Low
Liver 0.1 Low
Cell Line Expression
Cell Line nTPM Notes
NCI-H660 (prostate cancer) 0.3 Low expression
MCF7 (breast cancer) 0.1 Very low
LNCaP (prostate cancer) 0.2 Low
HepG2 (liver) 0.1 Very low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.277+1G>A Splice donor Rare Loss of function; associated with 46,XY DSD
c.325+4A>G Splice site Rare Loss of function; causes exon skipping
p.Arg80Trp Missense Rare Reduced enzyme activity
p.Gly289Ser Missense Rare Impaired catalytic activity
Mutation functional classification

Loss of Function (LOF)

Most reported mutations in HSD17B3 are loss-of-function, leading to reduced or absent 17β-HSD3 enzyme activity and impaired testosterone synthesis.

Gain of Function (GOF)

No gain-of-function mutations have been described in HSD17B3.

Dominant Negative (DN)

No dominant-negative effects have been reported for HSD17B3 mutations.

Pathways

Androgen biosynthesis (Reactome: R-HSA-196015)
Metabolism of steroids (Reactome: R-HSA-8957322)
Sexual differentiation (KEGG: hsa04913)

Protein Summary

17β-Hydroxysteroid dehydrogenase type 3 (17β-HSD3) is a 310-amino acid microsomal enzyme belonging to the short-chain dehydrogenase/reductase (SDR) family. It catalyzes the NADPH-dependent reduction of androstenedione to testosterone, a critical step in androgen biosynthesis. The enzyme is predominantly expressed in the testes, with minimal expression in other tissues. Defects in HSD17B3 cause 46,XY disorder of sex development due to testosterone deficiency.

Related Products

Product name Cat.No. Species Gene ID
HSD17B3 Knockout HEK293 Cell Line EDJ-KQ4949 Human 3293 Details Get a Quote
HSD17B3 Knockout HeLa Cell Line EDJ-KQ53577 Human 3293 Details Get a Quote
HSD17B3 Knockout A-549 Cell Line EDJ-KQ62043 Human 3293 Details Get a Quote
HSD17B3 Knockout HCT 116 Cell Line EDJ-KQ70525 Human 3293 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: